Co-Diagnostics (CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.
Co-Diagnostics (CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.